for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

Takeda reports positive interim results of Moderna trials in Japan

TOKYO, May 10 TK (Reuters) - Japanese drugmaker Takeda Pharmaceutical Co, which is importing Moderna Inc ‘s COVID-19 vaccine into Japan, said interim results of clinical trials ahead of domestic regulatory approvals have been positive.

“The vaccine candidate was generally well-tolerated with no significant safety concerns reported,” Takeda said in a statement. (Reporting by Rocky Swift and Ritsuko Ando in Tokyo; Editing by Kim Coghill)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up